Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Vallera

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal of Neuro-Oncology|September 4, 2003
Immunotoxin therapy for CNS tumorEdward Rustamzadeh, Walter C Low, Daniel A Vallera, et al.
Seminars in Immunology|September 9, 2017
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapyZachary B Davis, Daniel A Vallera, Jeffrey S Miller, et al.
Clinical Pharmacology : Advances and Applications|October 6, 2018
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxinFelix Oh, Deborah Todhunter, Elizabeth Taras, et al.
Human Gene Therapy|March 5, 2002
Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target geneNi Jin, Wei Chen, Bruce R Blazar, et al.
Toxins|January 11, 2018
Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell MalignanciesJoerg U Schmohl, Deborah Todhunter, Elizabeth Taras, et al.
Targeted Oncology|August 1, 2013
A bispecific EpCAM/CD133-targeted toxin is effective against carcinomaNate N Waldron, Sanford H Barsky, Phillip R Dougherty, et al.
Molecular Cancer Therapeutics|June 10, 2010
Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B-cell metastasesDaniel A Vallera, Seunguk Oh, Hua Chen, et al.
Journal of Neuro-Oncology|December 3, 2003
Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiformeEdward Rustamzadeh, Chunbin Li, Sekou Doumbia, et al.
Angewandte Chemie (International Ed. in English)|November 26, 2008
Self-assembly of antibodies by chemical inductionQing Li, David Hapka, Hua Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linkerJoerg U Schmohl, Martin Felices, Elizabeth Taras, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal of Neuro-Oncology|September 4, 2003
Immunotoxin therapy for CNS tumorEdward Rustamzadeh, Walter C Low, Daniel A Vallera, et al.
Seminars in Immunology|September 9, 2017
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapyZachary B Davis, Daniel A Vallera, Jeffrey S Miller, et al.
Clinical Pharmacology : Advances and Applications|October 6, 2018
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxinFelix Oh, Deborah Todhunter, Elizabeth Taras, et al.
Human Gene Therapy|March 5, 2002
Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target geneNi Jin, Wei Chen, Bruce R Blazar, et al.
Toxins|January 11, 2018
Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell MalignanciesJoerg U Schmohl, Deborah Todhunter, Elizabeth Taras, et al.
Targeted Oncology|August 1, 2013
A bispecific EpCAM/CD133-targeted toxin is effective against carcinomaNate N Waldron, Sanford H Barsky, Phillip R Dougherty, et al.
Molecular Cancer Therapeutics|June 10, 2010
Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B-cell metastasesDaniel A Vallera, Seunguk Oh, Hua Chen, et al.
Journal of Neuro-Oncology|December 3, 2003
Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiformeEdward Rustamzadeh, Chunbin Li, Sekou Doumbia, et al.
Angewandte Chemie (International Ed. in English)|November 26, 2008
Self-assembly of antibodies by chemical inductionQing Li, David Hapka, Hua Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linkerJoerg U Schmohl, Martin Felices, Elizabeth Taras, et al.
Pageof 9